These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1362950)

  • 1. Investigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.
    Poon GK; Chui YC; Jarman M; Rowlands MG; Kokkonen PS; Niessen WM; van der Greef J
    Drug Metab Dispos; 1992; 20(6):941-7. PubMed ID: 1362950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites.
    Kohler M; Parr MK; Opfermann G; Thevis M; Schlörer N; Marner FJ; Schänzer W
    Steroids; 2007 Mar; 72(3):278-86. PubMed ID: 17207827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
    Brodie AM; Son C; King DA; Meyer KM; Inkster SE
    Cancer Res; 1989 Dec; 49(23):6551-5. PubMed ID: 2479464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of 4-hydroxyandrost-4-ene-3,17-dione metabolism in breast cancer patients using high-performance liquid chromatography-mass spectrometry.
    Poon GK; Jarman M; Rowlands MG; Dowsett M; Firth J
    J Chromatogr; 1991 Apr; 565(1-2):75-88. PubMed ID: 1874906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptor.
    Davies JH; Shearer RJ; Rowlands MG; Poon GK; Houghton J; Jarman M; Dowsett M
    J Enzyme Inhib; 1992; 6(2):141-7. PubMed ID: 1284430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic studies of formestane in horses.
    Leung GN; Kwok WH; Wan TS; Lam KK; Schiff PJ
    Drug Test Anal; 2013 Jun; 5(6):412-9. PubMed ID: 23339113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of n-hexane metabolites by liquid chromatography/mass spectrometry. 2. Glucuronide-conjugated metabolites in untreated urine samples by electrospray ionization.
    Manini P; Andreoli R; Mutti A; Bergamaschi E; Niessen WM
    Rapid Commun Mass Spectrom; 1998; 12(21):1615-24. PubMed ID: 9807835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 4-hydroxyandrost-4-ene-3,17-dione metabolites in prostatic cancer patients by liquid chromatography-mass spectrometry.
    Poon GK; Jarman M; McCague R; Davies JH; Heeremans CE; van der Hoeven RA; Niessen WM; van der Greef J
    J Chromatogr; 1992 May; 576(2):235-44. PubMed ID: 1400711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of androst-4-ene-3,6,17-trione and metabolites in human urine after the administration of a food supplement by liquid chromatography/ion trap-mass spectrometry.
    Deventer K; Van Eenoo P; Mikulcíková P; Van Thuyne W; Delbeke FT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):21-6. PubMed ID: 16213800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of boldenone in man: gas chromatographic/mass spectrometric identification of urinary excreted metabolites and determination of excretion rates.
    Schänzer W; Donike M
    Biol Mass Spectrom; 1992 Jan; 21(1):3-16. PubMed ID: 1591280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.
    Przybylski M
    Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of 19-hydroxy- 19-oxo-, and aromatizing-activities in human placental microsomes through the use of suicide substrates to aromatase.
    Bednarski PJ; Nelson SD
    J Steroid Biochem; 1989 Feb; 32(2):309-16. PubMed ID: 2921872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the metabolism of propafenone. 3rd Comm.: Isolation of the conjugated metabolites in the dog and identification using fast atom bombardment mass spectrometry.
    Hege HG; Lietz H; Weymann J
    Arzneimittelforschung; 1986 Mar; 36(3):467-74. PubMed ID: 3707666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat.
    Goss PE; Jarman M; Wilkinson JR; Coombes RC
    J Steroid Biochem; 1986 Feb; 24(2):619-22. PubMed ID: 3509953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of metabolites in urine and feces from rats dosed with the heterocyclic amine, 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C).
    Frederiksen H; Frandsen H
    Drug Metab Dispos; 2004 Jun; 32(6):661-5. PubMed ID: 15155558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.
    Tang W; Abbott FS
    Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.